The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program

BACKGROUND: Increasing participation in the Australian National Bowel Cancer Screening Program (NBCSP) is the most efficient and cost-effective way of reducing mortality associated with colorectal cancer by detecting and treating early-stage disease. Currently, only 44% of Australians aged 50–74 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Anna, Emery, Jon D., Jenkins, Mark, Chondros, Patty, Campbell, Tina, Wenkart, Edweana, O’Reilly, Clare, Cowie, Tony, Dixon, Ian, Toner, Julie, Khalajzadeh, Hourieh, Gutierrez, Javiera Martinez, Govan, Linda, Buckle, Gemma, McIntosh, Jennifer G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753594/
https://www.ncbi.nlm.nih.gov/pubmed/35022080
http://dx.doi.org/10.1186/s13063-021-05877-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753594/
https://www.ncbi.nlm.nih.gov/pubmed/35022080
http://dx.doi.org/10.1186/s13063-021-05877-3

Ejemplares similares